Home » Topics » Regulatory » Patents

Patents
RSS

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Lilly claims new indication for olanzapine

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...